Resources

ASAM Applauds SAMHSA in Releasing New Treatment Improvement Protocol (TIP) 63

by ASAM Staff | March 1, 2018

American Society of Addiction Medicine Applauds SAMHSA in Releasing New Treatment Improvement Protocol (TIP) 63

A symposium session at the ASAM 49th Annual Conference will be dedicated to reviewing TIP 63.

The American Society of Addiction Medicine (ASAM) applauds the Substance Abuse and Mental Health Services Administration (SAMHSA) for the recently released Treatment Improvement Protocol (TIP) 63, Medications for Opioid Use Disorder (OUD). SAMHSA’s TIP 63 reviews the use of the three FDA-approved medications used to treat opioid addiction—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support recovery for people with opioid addiction. 

“It is very important to have up-to-date guidance from SAMHSA. We are thrilled that attendees at our annual conference in April will have the opportunity to attend a dedicated symposium session where they can learn more about TIP 63 from the Chair, Dr. Robert Schwartz, and expert panel member, Dr. Michelle Lofwall. TIP 63 will also be an important input as ASAM plans its focused update for its National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use later this year,” said ASAM President Kelly Clark, MD, MBA, DFAPA, DFASAM. 

In the United States, there is a public health crisis of overdose deaths from opioids, including heroin, illicit fentanyl, and prescription opioids. An estimated 1.8 million Americans have OUD related to prescription opioids1; 626,000 have heroin-related OUD1 with an estimated cost of over $504 billion.2

Treatment Improvement Protocols provide science-based best-practice guidance to the behavioral health field. They are designed for:

  • Physicians, physician assistants, and nurse practitioners: Offers guidance on appropriate prescribing practices for these medications
  • Addiction treatment providers, peer support workers, and recovery specialists: Provides effective strategies to support clients who take medication to treat OUD
  • Patients, families, and the public: Offers education on how OUD medications work and the benefits they offer

TIP 63 is available for download on the SAMHSA Store website. ASAM’s National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use is available for download on the ASAM website.

-end-

1 Council of Economic Advisers. (2017, November). The underestimated cost of the opioid crisis. Washington, DC: Executive Office of the President of the United States.

2 Center for Behavioral Health Statistics and Quality. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration.